نتایج جستجو برای: quality adjusted life year qaly

تعداد نتایج: 1895388  

2016
Lukas Jyuhn-Hsiarn Lee Cheng-Kuan Lin Mei-Chuan Hung Jung-Der Wang

This study estimates the annual numbers of eight work-related cancers, total losses of quality-adjusted life years (QALYs), and lifetime healthcare expenditures that possibly could be saved by improving occupational health in Taiwan. Three databases were interlinked: the Taiwan Cancer Registry, the National Mortality Registry, and the National Health Insurance Research Database. Annual numbers ...

Journal: :Medical decision making : an international journal of the Society for Medical Decision Making 2009
Jan J Barendregt

The half-cycle correction is often used in discrete Markov models to estimate state membership. This article shows that the correction, in addition to being unintuitive, actually produces the wrong results in many circumstances. These include quality-adjusted life year (QALY) weights and unit costs that differ by cycle. The half-cycle correction is also incompatible with discounting of the obta...

Journal: :Health economics 2014
Yuanyuan Gu Richard Norman Rosalie Viney

Using discrete choice experiments (DCEs) to estimate health state utility values has become an important alternative to the conventional methods of Time Trade-Off and Standard Gamble. Studies using DCEs have typically used the conditional logit to estimate the underlying utility function. The conditional logit is known for several limitations. In this paper, we propose two types of models based...

Journal: :Journal of medical ethics 1996
J McKie H Kuhse J Richardson P Singer

Harris levels two main criticisms against our original defence of QALYs (Quality Adjusted Life Years). First, he rejects the assumption implicit in the QALY approach that not all lives are of equal value. Second, he rejects our appeal to Rawls's veil of ignorance test in support of the QALY method. In the present article we defend QALYs against Harris's criticisms. We argue that some of the con...

2006
Lisa A. Prosser Carolyn Buxton Bridges Timothy M. Uyeki Virginia L. Hinrichsen Martin I. Meltzer Noelle-Angelique M. Molinari Benjamin Schwartz William W. Thompson Keiji Fukuda Tracy A. Lieu

We estimated cost-effectiveness of annually vaccinating children not at high risk with inactivated influenza vaccine (IIV) to range from US $12,000 per quality-adjusted life year (QALY) saved for children ages 6-23 months to $119,000 per QALY saved for children ages 12-17 years. For children at high risk (preexisting medical conditions) ages 6-35 months, vaccination with IIV was cost saving. Fo...

2017
J Haxby Abbott Ilana M Usiskin Ross Wilson Paul Hansen Elena Losina

BACKGROUND Knee osteoarthritis is a leading global cause of health-related quality of life loss. The aim of this project was to quantify health losses arising from knee osteoarthritis in New Zealand (NZ) in terms of quality-adjusted life years (QALYs) lost. METHODS The Osteoarthritis Policy Model (OAPol), a validated Monte Carlo computer simulation model, was used to estimate QALYs lost due t...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008
Robin de Vries Jan E A M van Bergen Lolkje T W de Jong-van den Berg Maarten J Postma

OBJECTIVE To estimate the cost-effectiveness of repeated screening for chlamydia trachomatis at various time intervals compared to one-off screening of Dutch young adults. METHODS We used a dynamic model to fully take the spread of the disease over time in the population into account, with data being used gathered within the context of a recently performed pilot study in The Netherlands. The ...

Journal: :Arquivos brasileiros de cardiologia 2010
Denizar Vianna Araújo Vanessa Teich Roberta Benitez Freitas Passos Sheila Cristina Ouriques Martins

BACKGROUND The cerebrovascular accident (CVA) or stroke is the main cause of death in Brazil and little information is available on the cost of treatment. OBJECTIVE To carry out a cost-effectiveness analysis of thrombolysis in stroke, up to three hours after symptom onset, comparing the treatment with alteplase versus the conservative treatment, under the perspective of the Brazilian Public H...

Introduction: In recent years, a few studies have been conducted in the area of the cost-effectiveness of the Eplerenone; it's notable that coherent and clear evidence are not available. Therefore, this study aimed to systematically review studies of cost-effectiveness of Eplerenone in the treatment of cardio-vascular patients. Methods: This systematic review study was conducted in 2016. The...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید